Trial record 1 of 1 for:    NCT01253395
Previous Study | Return to List | Next Study

Exercise for Fibromyalgia

This study has been completed.
Information provided by:
Mayo Clinic Identifier:
First received: December 1, 2010
Last updated: December 2, 2010
Last verified: December 2010
Randomized equivalency trial of the effects of strength training compared to aerobic exercise on pain severity in adults with fibromyalgia.

Condition Intervention
Behavioral: Strength training
Behavioral: Aerobic exercise

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Bio-equivalence Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Randomized Equivalency Trial of Strength Compared to Aerobic Exercise on Pain Severity in Adults With Fibromyalgia

Resource links provided by NLM:

Further study details as provided by Mayo Clinic:

Primary Outcome Measures:
  • Pain severity [ Time Frame: Week 3 ] [ Designated as safety issue: No ]
    Validated measure of clinical pain.

Secondary Outcome Measures:
  • Muscle strength [ Time Frame: Week 3 ] [ Designated as safety issue: No ]
    Assessment of muscle strength using a dynometer.

Enrollment: 72
Study Start Date: April 2006
Study Completion Date: April 2008
Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Strength training
Supervised strength training.
Behavioral: Strength training
Daily supervised strength training.
Active Comparator: Aerobic exercise
Supervised aerobic exercise.
Behavioral: Aerobic exercise
Daily supervised aerobic exercise.


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both

Inclusion Criteria:

- Established diagnosis of fibromyalgia, age > 18 years. Exclusion Criteria: cardiac, pulmonary or orthopedic condition that would limit exercise.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01253395

United States, Minnesota
Mayo Clinic
Rochester, Minnesota, United States, 55905
Sponsors and Collaborators
Mayo Clinic
Principal Investigator: William M Hooten, MD Mayo Clinic
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: W. Michael Hooten, Md, Mayo Clinic Identifier: NCT01253395     History of Changes
Other Study ID Numbers: 005-4167 
Study First Received: December 1, 2010
Last Updated: December 2, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Mayo Clinic:

Additional relevant MeSH terms:
Myofascial Pain Syndromes
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neuromuscular Diseases
Rheumatic Diseases processed this record on May 25, 2016